Novo Nordisk As Stock Price on November 12, 2024
| NVO Stock | USD 105.75 2.86 2.63% |
Below is the normalized historical share price chart for Novo Nordisk AS extending back to April 30, 1981. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novo Nordisk stands at 105.75, as last reported on the 13th of December 2024, with the highest price reaching 105.75 and the lowest price hitting 105.75 during the day.
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. Novo Nordisk AS has Sharpe Ratio of -0.2, which conveys that the firm had a -0.2% return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Mean Deviation of 1.32, risk adjusted performance of (0.13), and Standard Deviation of 1.74 to check out the risk estimate we provide.
At this time, Novo Nordisk's Total Stockholder Equity is very stable compared to the past year. As of the 13th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 330.2 B, while Common Stock Shares Outstanding is likely to drop about 3.7 B. . At this time, Novo Nordisk's Price Cash Flow Ratio is very stable compared to the past year. As of the 13th of December 2024, Price Sales Ratio is likely to grow to 14.15, though Price Earnings To Growth Ratio is likely to grow to (1.49). Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 1982 | 200 Day MA 128.1924 | 50 Day MA 118.5756 | Beta 0.165 |
Novo |
Sharpe Ratio = -0.1984
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVO |
Estimated Market Risk
| 1.77 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.
Price Book 29.1549 | Enterprise Value Ebitda 25.3713 | Price Sales 1.8181 | Shares Float 3.2 B | Dividend Share 9.9 |
Related Headline
Alnylam Pharmaceuticals Headline on 12th of November 2024
Alnylam downgraded at Wolfe on doubts over Amvuttra growth by seekingalpha.com
Wolfe downgrades Alnylam Pharmaceuticals to underperform issuing a contrarian view on the pharma company. Read more here.
Novo Nordisk Valuation on November 12, 2024
It is possible to determine the worth of Novo Nordisk on a given historical date. On November 12, 2024 Novo was worth 106.81 at the beginning of the trading date compared to the closed value of 107.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novo Nordisk stock. Still, in general, we apply an absolute valuation method to find Novo Nordisk's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novo Nordisk where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novo Nordisk's related companies.
| Open | High | Low | Close | Volume | |
| 109.67 | 110.61 | 108.93 | 109.09 | 4,701,422 | |
11/12/2024 | 106.81 | 107.61 | 105.70 | 107.06 | 4,838,098 |
| 106.88 | 107.79 | 106.55 | 106.91 | 3,086,355 |
| Backtest Novo Nordisk | | | Novo Nordisk History | | | Novo Nordisk Valuation | Previous | Next |
Novo Nordisk Trading Date Momentum on November 12, 2024
| On November 13 2024 Novo Nordisk AS was traded for 106.91 at the closing time. Highest Novo Nordisk's price during the trading hours was 107.79 and the lowest price during the day was 106.55 . The net volume was 3.1 M. The overall trading history on the 13th of November 2024 contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.14% . The trading delta at closing time to current price is 2.94% . |
Novo Nordisk AS Fundamentals Correlations and Trends
By evaluating Novo Nordisk's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novo Nordisk's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novo Nordisk Stock history
Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.5 B | 3.7 B | |
| Net Income Applicable To Common Shares | 63.9 B | 67 B |
Novo Nordisk Stock Technical Analysis
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novo Nordisk Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Novo Nordisk AS cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novo Nordisk December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk stock market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns
Novo Nordisk Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | 6.08 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.224 | Dividend Share 9.9 | Earnings Share 2.99 | Revenue Per Share 60.698 | Quarterly Revenue Growth 0.214 |
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.